Home / Inspections / 1037244

FDA Inspection 1037244 — Dhaliwal Labs South LLC

Dhaliwal Labs South LLC — FEI 3007410731

The FDA completed an inspection of Dhaliwal Labs South LLC on December 20, 2017 in Dallas, TX. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Veterinary.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
December 20, 2017
Fiscal Year
2018
Product Type
Veterinary
Project Area
Monitoring of Marketed Animal Drugs, Feed, and Devices
Location
Dallas, TX (United States)

Facility

Other inspections at this facility

  • 1274979 (VAI Thu Jun 26 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1200800 (VAI Tue Feb 07 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1087733 (VAI Thu Apr 25 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 976273 (VAI Tue Jun 14 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 884574 (VAI Fri Jun 20 2014 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources